Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.

摘要

TO THE EDITOR: Determining empiric therapy for treatment of urinary tract infections (UTIs) in hospitalized patients is a critical and intricate process due to higher resistance and variability of causative pathogens than in community-associated UTIs. Ciprofloxacin is often the treatment of choice for hospitalized patients with UTIs; however, the prevalence of fluoroquinolone resistance against uropathogens has progressively risen, with ciprofloxacin resistance in hospitalized patients found to be as high as 25% as of 2005.